Recombinant expression vector applicable to rapid screening for recombinant strain and application
US-12037632-B2 · Jul 16, 2024 · US
US9611462B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9611462-B2 |
| Application number | US-201214366761-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 18, 2012 |
| Priority date | Dec 20, 2011 |
| Publication date | Apr 4, 2017 |
| Grant date | Apr 4, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides endoglucanase 1b (EG1b) variants suitable for use in saccharification reactions. The present application further provides genetically modified fungal organisms that produce EG1b variants, as well as enzyme mixtures exhibiting enhanced hydrolysis of cellulosic material to fermentable sugars, enzyme mixtures produced by the genetically modified fungal organisms, and methods for producing fermentable sugars from cellulose using such enzyme mixtures.
Opening claim text (preview).
We claim: 1. A variant endoglucanase or enzymatically active fragment thereof comprising (a) an amino acid sequence at least 80% identical to the wild-type endoglucanase amino acid sequence of SEQ ID NO:3; and (b) an amino acid substitution introducing an amino acid other than phenylalanine at position 63, wherein the residue positions are numbered with reference to SEQ ID NO:2. 2. The variant endoglucanase of claim 1 , wherein the variant comprises one or more amino acid substitutions selected from P34, T38, W39, T43, Q49, E66, S75, D85, N126, G137, V143, Q201, N218, K228, S241, S269, M274, D282, S328, L342, L342, G350, D397, T398, G399, D400, G401, N403, N403, N404, G405, G407, P408, P408, N409, S411, S412, T413, T414, T415, T417, T417, A418, T419, T420, P425, P428, Y433, G434, Q435, Q435, G438, K439, G440, G443, P444, R446, N457, and L464, wherein the residues are numbered with reference to SEQ ID NO:2. 3. The variant endoglucanase of claim 1 , wherein the variant comprises one or more amino acid substitutions selected from 34R, 38A, 39R, 43C, 49R, 66R, 75P, 85V, 126K, 137T, 143M, 201L, 201M, 218S, 228F, 241K, 269L, 274V, 282G, 328Q, 342F, 342A, 350S, 397Y, 398M, 399C, 400R, 401D, 403D, 403M, 404L, 405C, 405Y, 405W, 407R, 408E, 408G, 409W, 411A, 412Q, 413E, 413P, 414L, 415G, 417G, 417H, 418C, 418S, 419G, 420G, 420I, 420L, 420K, 425S, 425L, 428C, 428V, 433F, 433V, 434D, 434P, 435G, 435K, 435R, 438A, 439P, 440D, 440R, 440T, 443E, 443S, 444Q, 446G, 457H, and 464Q, wherein the residues are numbered with reference to SEQ ID NO:2. 4. The variant endoglucanase of claim 1 , wherein the variant comprises at least one substitution selected from N403D/M, T419G, P425L, N404L, P428V, L340M, D400R, A418S, G440D, N346D, G401D, Q435G, R446G, and T417G, wherein the residues are numbered with reference to SEQ ID NO:2. 5. A variant endoglucanase comprising an enzymatically active endoglucanase amino acid sequence wherein an amino acid substitution introduces an amino acid other than phenylalanine at position 63 and having at least 80% identity to an amino acid sequence set forth in any of SEQ IDs NOs:5, 7 or 9. 6. The variant endoglucanase of claim 1 , wherein the variant is a variant of the Myceliophthora thermophila EG 1b amino acid sequence of SEQ ID NO:2. 7. The variant endoglucanase of claim 1 , wherein the variant has increased thermoactivity at pH of about 4-5 and a temperature of about 65° C. in comparison to the wild-type endoglucanase 1b set forth in SEQ ID NO:3. 8. The variant endoglucanase of claim 1 , wherein the variant has increased activity on cellulose in comparison to the wild-type endoglucanase 1b set forth in SEQ ID NO:3. 9. An enzyme composition comprising the variant endoglucanase of claim 1 . 10. The enzyme composition of claim 9 , further comprising at least one additional enzyme. 11. The enzyme composition of claim 9 , further comprising one or more enzyme(s) selected from other endoglucanases (EG), β-glucosidases (BGL), Type 1 cellobiohydrolases (CBH1), and/or Type 2 cellobiohydrolases (CBH2). 12. A method for producing at least one fermentable sugar from a biomass substrate, comprising contacting the biomass substrate with the enzyme composition according to claim 9 , under culture conditions whereby fermentable sugars are produced. 13. The method of claim 12 , wherein the enzyme composition comprises at least one enzyme selected from other endoglucanases (EG), β-glucosidases (BGL), Type 1 cellobiohydrolases (CBH1), and Type 2 cellobiohydrolases (CBH2).
produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title
Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150) · CPC title
Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase · CPC title
Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.